Cargando…
Morphine may act via DDX49 to inhibit hepatocellular carcinoma cell growth
Pain in hepatocellular carcinoma (HCC) is a frequent cause of low quality of life, and morphine is routinely used as a first-line opiate analgesic in HCC. Morphine may exert not only analgesic effects but also anti-cancer effects via unknown mechanisms. Here we show that morphine can inhibit HCC cel...
Autores principales: | Dai, Huijun, Feng, Jifeng, Nan, Zhenhua, Wei, Lijuan, Lin, Fei, Jin, Ren, Zhang, Suisui, Wang, Xiaoxia, Pan, Linghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148497/ https://www.ncbi.nlm.nih.gov/pubmed/33952717 http://dx.doi.org/10.18632/aging.202946 |
Ejemplares similares
-
Celecoxib Inhibits Hepatocellular Carcinoma Cell Growth and Migration by Targeting PNO1
por: Dai, Huijun, et al.
Publicado: (2019) -
Overexpression of DDX49 in prostate cancer is associated with poor prognosis
por: Tao, Junyue, et al.
Publicado: (2023) -
DDX49 is a novel biomarker and therapeutic target for lung cancer metastases
por: Lian, Xiaojuan, et al.
Publicado: (2019) -
DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway
por: Shen, Lin, et al.
Publicado: (2022) -
DExD/H Box Helicases DDX24 and DDX49 Inhibit Reactivation of Kaposi’s Sarcoma Associated Herpesvirus by Interacting with Viral mRNAs
por: Serfecz, Jacquelyn C., et al.
Publicado: (2022)